MDSteps Library Preview
You’ve viewed 0 of 3 free topics. Test the next topic with a free MDSteps reasoning diagnostic.
Try Free Diagnostic
MDSteps- USMLE® Reference Library

Emphysematous Pyelonephritis - Diabetes and Urgent Drainage

System: Urology • Reviewed: Aug 15, 2026 • Step 1Step 2Step 3
Written by: Keemia Heidari, MD • Reviewed by: Michael Laberge, MD

Synopsis:

Emphysematous pyelonephritis is a necrotizing gas-forming renal infection, strongly associated with diabetes and urinary obstruction, that can rapidly cause septic shock and multiorgan failure. Treatment requires immediate sepsis resuscitation, broad-spectrum IV antibiotics, CT definition of gas and obstruction, urgent drainage of an obstructed or infected collecting system, glucose control, and early urology/interventional radiology involvement. Nephrectomy is reserved for failure of less invasive source c

Medical library → exam application

Reading is the easy part. Applying it in a vignette is where points are won.

Use this topic page for the facts, then take a free MDSteps-style question to see the pivot clue, the distractor trap, and the reasoning step that decides the answer.

Topic reviewed Pivot clue isolated Distractor logic explained
Answer free sample questions and see how MDSteps identifies the decision patterns costing you points.

Key Points

  • Emphysematous pyelonephritis is a necrotizing gas-forming renal infection with high sepsis risk.
  • Diabetes and urinary obstruction are the major predisposing factors.
  • CT defines gas distribution, obstruction and drainable collections.
  • Start broad-spectrum IV antibiotics and sepsis treatment immediately.
  • Infected obstruction requires urgent urinary decompression.
  • Percutaneous drainage plus antibiotics preserves kidneys in many patients and has replaced routine immediate nephrectomy.
  • Nephrectomy is reserved for failed conservative source control or extensive nonviable disease.
  • Control hyperglycemia and evaluate for DKA/HHS because metabolic decompensation is common.

Algorithm

  1. Recognize severe/atypical pyelonephritis in diabetes, obstruction, stones or septic shock.
  2. Obtain blood/urine cultures, CBC, CMP, lactate, glucose, coagulation and acid-base studies.
  3. Perform urgent CT to identify renal gas, collections and obstruction.
  4. Begin IV broad-spectrum antibiotics and sepsis resuscitation.
  5. If obstruction or collection exists, obtain urgent urology/interventional radiology drainage.
  6. Control glucose and treat DKA/HHS or other metabolic complications.
  7. Escalate to nephrectomy if sepsis progresses despite adequate antibiotics/drainage or kidney is extensively destroyed.
  8. Narrow antibiotics to culture results and confirm resolution of obstruction/infection before discharge.

Clinical Synopsis & Reasoning

Emphysematous pyelonephritis should be suspected in a severely ill patient with pyelonephritis, particularly with diabetes, urinary obstruction, stones, CKD, immunosuppression, or poor response to initial antibiotics. Fever, flank pain, nausea, altered mental status, hypotension and hyperglycemia are common, but older or immunocompromised patients may have subtle symptoms. Gas can be confined to the collecting system or extend into renal parenchyma and perinephric tissues. Pneumaturia is uncommon unless there is fistula or lower urinary gas.

Contrast CT, when renal function and hemodynamics permit, is the diagnostic imaging standard because it defines parenchymal gas, fluid collections, obstruction, stones and extension beyond the kidney. Noncontrast CT is still highly sensitive for gas and stones when contrast is unsafe. Obtain urine and blood cultures before antibiotics when this does not delay therapy. CBC, CMP, lactate, glucose, coagulation tests and acid-base assessment define sepsis severity. Thrombocytopenia, AKI, shock, altered mental status and extensive bilateral/solitary-kidney disease are markers of high risk. Gas in the urinary tract also has a differential including recent instrumentation, fistula and emphysematous cystitis.


Treatment Strategy & Disposition

Treat as complicated systemic UTI with sepsis when organ dysfunction is present. Give IV crystalloid based on perfusion and comorbidity, obtain cultures, and start broad-spectrum IV antibiotics active against Enterobacterales and other local pathogens. Piperacillin-tazobactam, an extended-spectrum cephalosporin, or a carbapenem for patients at high ESBL/resistance risk are common empiric strategies, then narrow to cultures. Nitrofurantoin and oral fosfomycin are not appropriate for pyelonephritis because they do not achieve adequate renal tissue concentrations.

Source control is crucial. An infected obstructed collecting system requires urgent decompression with percutaneous nephrostomy or ureteral stent. Percutaneous drainage of renal/perinephric collections plus antibiotics has shifted management away from routine immediate nephrectomy and preserves renal tissue in many patients. Nephrectomy remains necessary when the patient deteriorates despite antibiotics and drainage, when there is extensive necrotic nonfunctional kidney, or when adequate drainage cannot control sepsis. Control severe hyperglycemia, correct electrolytes, manage DKA/HHS if present, and involve ICU early for shock or respiratory failure. Follow imaging and clinical response until infection and obstruction are definitively resolved.


Epidemiology / Risk Factors

  • Most patients have diabetes, often with poor glycemic control.
  • Urinary tract obstruction from stones, strictures or other lesions is another major risk factor.
  • E. coli and Klebsiella species are common pathogens.
  • Mortality has fallen with CT diagnosis, critical care, antibiotics and percutaneous drainage but remains substantial in shock.

Investigations

TestRole / RationaleTypical FindingsNotes
CT abdomen/pelvisDefines gas, obstruction and collectionsGas in collecting system/parenchyma/perinephric spaceKey diagnostic and procedural-planning study
Urine cultureIdentifies pathogen/susceptibilityOften EnterobacteralesObtain before antibiotics if no delay
Blood culturesDetects bacteremiaMay be positiveImportant in septic patients
CBCAssesses leukocytosis, thrombocytopeniaWBC high/low; low platelets high riskTrend with sepsis
Creatinine/electrolytesAssesses AKI and metabolic complicationsAKI commonGuides dosing and dialysis need
Glucose/ketones/acid-baseAssesses diabetes decompensationHyperglycemia, DKA/HHS possibleTreat concurrently
LactateTracks sepsis hypoperfusionMay be elevatedTrend resuscitation

Risk Factors and Clues

FactorComment
DiabetesMost common predisposing condition; optimize glucose control
Urinary obstruction/stoneRequires urgent decompression plus later definitive management
Shock or altered mental statusHigh-risk presentation requiring ICU-level care
Thrombocytopenia/AKIMarkers associated with severe disease
Bilateral or solitary-kidney diseaseFavor kidney-preserving drainage when feasible while controlling sepsis

Pharmacology

MedicationMechanismOnsetRole in TherapyLimitations
Piperacillin-tazobactamBroad beta-lactam/beta-lactamase inhibitorHoursEmpiric severe complicated UTI in selected local-resistance settingsRenal dosing, allergy, resistant ESBL organisms
Ceftriaxone/cefepimeCephalosporin cell-wall inhibitionHoursEmpiric therapy according to severity/resistance riskSpectrum differs; renal dosing for cefepime
CarbapenemBroad beta-lactam stable to many ESBL enzymesHoursHigh ESBL/MDR risk or confirmed susceptible indicationStewardship, seizures/interactions vary by agent
InsulinLowers glucose and suppresses ketogenesisMinutes-hoursSevere hyperglycemia/DKA/HHSHypoglycemia, potassium shifts
VasopressorSupports perfusion pressureMinutesSeptic shock after appropriate fluid resuscitationRequires ICU monitoring

Prognosis / Complications

  • Early antibiotics plus successful drainage can preserve renal function and avoid nephrectomy.
  • Shock, thrombocytopenia, altered mental status, severe AKI and extensive disease predict worse outcome.
  • Delayed decompression of an infected obstructed system increases sepsis mortality.
  • Survivors require follow-up for stones/obstruction, renal function and diabetes control to reduce recurrence.

Patient Education / Counseling

  • Explain that gas-forming infection is more severe than routine kidney infection and often requires a drainage procedure.
  • Patients with diabetes should receive a clear glucose management plan and sick-day guidance after recovery.
  • Report recurrent fever, flank pain, vomiting, reduced urine or confusion urgently.
  • Complete the prescribed antibiotic course and attend urology follow-up for definitive stone or obstruction treatment.
  • If a nephrostomy or stent remains at discharge, follow device-care and exchange/removal instructions carefully.

Notes

Emphysematous pyelonephritis is a source-control disease. Antibiotics are essential but cannot reliably sterilize an obstructed collecting system or large necrotic collection. The modern kidney-preserving approach uses percutaneous nephrostomy/stenting and drainage early, reserving nephrectomy for patients who fail adequate drainage or have unrecoverable destructive disease.

After acute survival, prevention is not complete until the underlying obstruction, stone burden, device issue or metabolic risk is addressed. A patient discharged with a stent or nephrostomy needs a definite follow-up date, because forgotten urinary devices become future infection and encrustation hazards.


References

  1. EAU Guidelines on Urological Infections — Link
Turn review into score movement

Practice the decision pattern next.

Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.

  • Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
  • 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
  • Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
  • CCS cases with live vitals, order timing, reassessment, and after-action feedback
Topic reviewed Pivot clue isolated Distractor logic explained

You’ve reached your MDSteps Library preview limit

Unlock the full Medical Library and use it the way it was built to work: alongside your QBank review, CCS practice, and personalized study tools.

  • Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
  • 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
  • Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
  • CCS cases with live vitals, order timing, reassessment, and after-action feedback